Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 25, 2003

View Archived Issues

CX-659S prevents rebound after prednisolone treatment

Effective use of sumatriptan in OCD

Good efficacy and safety profile established for atlizumab in rheumatoid arthritis

Antitumor effects described for SU-11654 in spontaneous canine tumors

Potential of levetiracetam in neuropathic pain

Genta acquires license to siRNA

Long-term efficacy of Retaane demonstrated in 24-month wet AMD trial

Fougera's lidocaine/prilocaine cream approved by FDA

NicOx and Merck sign research evaluation agreement for nitric oxide-donating drugs

IND filed for Atrigel formulation of octreotide

Fast track designation awarded to ABthrax

Merck & Co. discontinues development of first Karo Bio collaboration compound

Phase I bridging study of LEP-ETU commences

Levitra receives FDA approval

Thalidomide recommended for approval in Australia

Priority review for Vitrase NDA

Janssen patent covers prucalopride N-oxide isomers and their use

New acetylcholine receptor modulators in early development at Merck KGaA

Axovan scientists present novel antiobesity NPY Y5 antagonists

New PARP inhibitors and their use in ischemia-reperfusion injury

New alphavbeta3/alphavbeta5 antagonists prepared and tested at Bayer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
First phase of synthetic human genome project successfully completes
BioWorld Science
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...